1887

Abstract

Five monoclonal antibodies specific for glycoprotein gp50 of pseudorabies virus were used to make a topographical map of gp50 and to determine the biological function of the different antigenic domains. Three antigenic domains were identified by competition binding assays and additivity assays (IA, IB, II). Domain IA corresponds to a continuous epitope, whereas domains IB and II consist of one or several discontinuous epitopes, identified by their resistance to heat or reducing treatments. Domains IA and IB correspond to sites highly involved in virus neutralization. Neutralization experiments by monoclonal antibodies recognizing domains IA and IB and performed before or after adsorption of virions to cells showed that these domains have a role in penetration of virus into the cell.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-9-2179
1990-09-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/9/JV0710092179.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-9-2179&mimeType=html&fmt=ahah

References

  1. Eisenberg R. J., Long D., Pereira L., Hampar B., Zweig M., Cohen G. H. 1982; Effect of monoclonal antibody on limited proteolysis of native glycoprotein D of herpes simplex virus. Journal of Virology 41:478–488
    [Google Scholar]
  2. Eisenberg R. J., Long D., Ponce de Leon M., Matthews J. T., Spear P. G., Gibson M. G., Laskey L. A., Berman P., Golub E., Cohen G. H. 1985; Localisation of epitopes of herpes simplex virus type 1 glycoprotein D. Journal of Virology 53:634–644
    [Google Scholar]
  3. Eloit M., Fargeaud D., L’Haridon R., Toma B. 1988; Identification of the pseudorabies virus gp50 as a major target of neutralizing antibodies. Archives of Virology 99:45–56
    [Google Scholar]
  4. Eloit M., Fargeaud D., Vannier P., Toma B. 1989; Development of an ELISA test to differentiate between animals either vaccinated with or infected by Aujeszky’s disease virus. Veterinary Record 124:91–94
    [Google Scholar]
  5. Friguet B., Djavadi-Ohaniance L., Pages J., Bussard A., Goldberg M. 1983; A convenient ELISA for testing whether monoclonal antibodies recognize the same antigenic site. Journal of Immunological Methods 60:351–358
    [Google Scholar]
  6. Hampl H., Ben-Porat T., Ehrlicher L., Habermehl K., Kaplan A. S. 1984; Characterization of the envelope proteins of pseudorabies virus. Journal of Virology 52:583–590
    [Google Scholar]
  7. Highlander S. L., Sutherland S. L., Gage P. L., Johnson D. C., Levine M., Glorioso J. C. 1987; Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Journal of Virology 61:3356–3364
    [Google Scholar]
  8. Hughes G., Bauiuk L. A., van Drunen Littel-van den Hurk S. 1988; Functional and topographical analysis of bovine herpes virus type 1 glycoprotein gIV. Archives of Virology 103:47–60
    [Google Scholar]
  9. Ishii H., Kobayashi Y., Kuroki M., Kodama Y. 1988; Protection of mice from lethal infection with Aujeszky’s disease virus by immunization with purified gVI. Journal of General Virology 69:1411–1414
    [Google Scholar]
  10. Laurent A. G., Gruest J., Krust B., Montagnier L. 1982; Characterization of monoclonal antibody specific for human alpha interferon. Hybridoma 1:313–322
    [Google Scholar]
  11. Marchioli C. C., Yancey R. J., Petrovskis E. A., Timmins J. G., Post L. E. 1987; Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky’s disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. Journal of Virology 61:3977–3982
    [Google Scholar]
  12. Mettenleiter T. C. 1989; Glycoprotein GUI deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171:623–625
    [Google Scholar]
  13. Minson A. C., Hodgman T. C., Digard P., Hancock D. C., Bell S. E., Buckmaster E. A. 1986; An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. Journal of General Virology 67:1001–1013
    [Google Scholar]
  14. Nakane P. K., Kawoi A. 1974; Peroxidase-labelled antibody: a new method of conjugation. Journal of Histochemistry and Cytochemistry 22:1084–1096
    [Google Scholar]
  15. Petrovskis E. A., Timmins J. G., Armentrout M. A., Marchioli C. C., Yancey R. J., Post L. E. 1986; DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation. Journal of Virology 59:216–223
    [Google Scholar]
  16. Rea T. J., Timmins J. G., Long G. W., Post L. E. 1985; Mapping and sequence of the gene for the pseudorabies virus glycoprotein which accumulates in the medium of infected cells. Journal of Virology 54:21–29
    [Google Scholar]
  17. Schreurs C., Mettenleiter T. C., Zuckermann F., Sugg N., Ben-Porat T. 1988; Glycoprotein gIII of pseudorabies virus is multifunctional. Journal of Virology 62:2251–2257
    [Google Scholar]
  18. Wathen M. W., Wathen L. M. K. 1984; Isolation, characterization and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. Journal of Virology 51:57–62
    [Google Scholar]
  19. Wathen L. M. K., Platt K. B., Wathen M. W., Van Deusen R. A., Whetstone C. A., Pirtle E. C. 1985; Production and characterization of monoclonal antibodies directed against pseudorabies virus. Virus Research 4:19–29
    [Google Scholar]
  20. Wilcox W. C., Long D., Sodora D. L., Eisenberg R. J., Cohen G. H. 1988; The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D. Journal of Virology 62:1941–1947
    [Google Scholar]
  21. Zuckermann F. A., Zsak L., Reilly L., Sugg N., Ben-Porat T. 1989; Early interactions of pseudorabies virus with host cells: functions of glycoprotein gIII. Journal of Virology 63:3323–3329
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-9-2179
Loading
/content/journal/jgv/10.1099/0022-1317-71-9-2179
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error